Related references
Note: Only part of the references are listed.Aurora kinase inhibitory VX-680 increases Bax/Bcl-2 ratio and induces apoptosis in Aurora-A-high acute myeloid leukemia
Xue-Fei Huang et al.
BLOOD (2008)
VX-680 inhibits Aurora A and Aurora B kinase activity in human cells
Rebecca K. Tyler et al.
CELL CYCLE (2007)
Aurora-a, a negative prognostic marker, increases migration and decreases radiosensitivity in cancer cells
Zhong Guan et al.
CANCER RESEARCH (2007)
AZD1152, a novel and selective aurora B kinase inhibitor, induces growth arrest, apoptosis, and sensitization for tubulin depolymerizing agent or topoisomerase II inhibitor in human acute leukemia cells in vitro and in vivo
Jing Yang et al.
BLOOD (2007)
Ionizing radiation predisposes nonmalignant human mammary epithelial cells to undergo transforming growth factor β-induced epithelial to mesenchymal transition
Kurnari L. Andarawewa et al.
CANCER RESEARCH (2007)
Antitumor activity of MLN8054, an orally active small-molecule inhibitor of Aurora A kinase
Mark G. Manfredi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Aurora-A regulation of nuclear factor-κB signaling by phosphorylation of IκBα
Paraskevi Briassouli et al.
CANCER RESEARCH (2007)
Aurora kinase inhibition downregulates NF-κB and sensitises tumour cells to chemotherapeutic agents
Chongbo Sun et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
The role of epithelial-mesenchymal transition in cancer pathology
Marcello Guarino et al.
PATHOLOGY (2007)
Arrestin-2 and G protein-coupled receptor kinase 5 interact with NFκB1 p105 and negatively regulate lipopolysaccharide-stimulated ERK1/2 activation in macrophages
Narayanan Parameswaran et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Aurora kinase A messenger RNA overexpression is correlated with tumor progression and shortened survival in head and neck squamous cell carcinoma
Rudolf Reiter et al.
CLINICAL CANCER RESEARCH (2006)
AURKA is one of the downstream targets of MAPK1/ERK2 in pancreatic cancer
T. Furukawa et al.
ONCOGENE (2006)
Hepatocyte growth factor induces cell scattering through MAPK/Egr-1-mediated upregulation of Snail
Stefan Grotegut et al.
EMBO JOURNAL (2006)
Targeting aurora kinases for the treatment of prostate cancer
Edmund Chun Yu Lee et al.
CANCER RESEARCH (2006)
NF-κB and IKK as therapeutic targets in cancer
HJ Kim et al.
CELL DEATH AND DIFFERENTIATION (2006)
Aurora A, mitotic entry, and spindle bipolarity
Q Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The epithelial-mesenchymal transition: new insights in signaling, development, and disease
JM Lee et al.
JOURNAL OF CELL BIOLOGY (2006)
Dynamic localization and functional implications of Aurora-C kinase during male mouse meiosis
CJC Tang et al.
DEVELOPMENTAL BIOLOGY (2006)
EFA6A enhances glioma cell invasion through ADP ribosylation factor 6/extracellular signal-regulated kinase signaling
M Li et al.
CANCER RESEARCH (2006)
Structure of the kinase domain of an imatinib-resistant Abl mutant in complex with the aurora kinase inhibitor VX-680
MA Young et al.
CANCER RESEARCH (2006)
The focal adhesion scaffolding protein HEF1 regulates activation of the Aurora-A and Nek2 kinases at the centrosome
EN Pugacheva et al.
NATURE CELL BIOLOGY (2005)
Induction of an epithelial to mesenchymal transition in human immortal and malignant keratinocytes by TGF-β1 involves MAPK, Smad and AP-1 signalling pathways
M Davies et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2005)
β-Catenin and TGFβ signalling cooperate to maintain a mesenchymal phenotype after FosER-induced epithelial to mesenchymal transition
A Eger et al.
ONCOGENE (2004)
Correcting improper chromosome-spindle attachments during cell division
MA Lampson et al.
NATURE CELL BIOLOGY (2004)
VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo
EA Harrington et al.
NATURE MEDICINE (2004)
Aurora kinases link chromosome segregation and cell division to cancer susceptibility
P Meraldi et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2004)
Activation of the Erk pathway is required for TGF-β1-induced EMT in vitro
X Lu et al.
NEOPLASIA (2004)
The chromosomal passenger complex is required for chromatin-induced microtubule stabilization and spindle assembly
SC Sampath et al.
CELL (2004)
Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis
S Grünert et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores
C Ditchfield et al.
JOURNAL OF CELL BIOLOGY (2003)
The small molecule Hesperadin reveals a role for Aurora B in correcting kinetochore-microtubule attachment and in maintaining the spindle assembly checkpoint
S Hauf et al.
JOURNAL OF CELL BIOLOGY (2003)
Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion
ZM Lu et al.
CANCER CELL (2003)
Epithelial-mesenchymal transitions in tumour progression
JP Thiery
NATURE REVIEWS CANCER (2002)
Aurora-A overexpression reveals tetraploidization as a major route to centrosome amplification in p53-/- cells
P Meraldi et al.
EMBO JOURNAL (2002)
Ras and TGFβ cooperatively regulate epithelial cell plasticity and metastasis:: dissection of Ras signaling pathways
E Janda et al.
JOURNAL OF CELL BIOLOGY (2002)
IGF-II induces rapid β-catenin relocation to the nucleus during epithelium to mesenchyme transition
OG Morali et al.
ONCOGENE (2001)
The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells
E Batlle et al.
NATURE CELL BIOLOGY (2000)